KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$190.6 million.

  • Emergent BioSolutions' Net Income towards Common Stockholders fell 55.40% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 136.35%. This contributed to the annual value of -$190.6 million for FY2024, which is 74.94% up from last year.
  • Emergent BioSolutions' Net Income towards Common Stockholders amounted to -$190.6 million in FY2024, which was up 74.94% from -$760.5 million recorded in FY2023.
  • Over the past 5 years, Emergent BioSolutions' Net Income towards Common Stockholders peaked at $305.8 million during FY2020, and registered a low of -$760.5 million during FY2023.
  • For the 3-year period, Emergent BioSolutions' Net Income towards Common Stockholders averaged around -$387.6 million, with its median value being -$211.6 million (2022).
  • As far as peak fluctuations go, Emergent BioSolutions' Net Income towards Common Stockholders soared by 461.10% in 2020, and later tumbled by 259.40% in 2023.
  • Emergent BioSolutions' Net Income towards Common Stockholders (Yearly) stood at $305.8 million in 2020, then fell by 28.22% to $219.5 million in 2021, then slumped by 196.40% to -$211.6 million in 2022, then crashed by 259.40% to -$760.5 million in 2023, then spiked by 74.94% to -$190.6 million in 2024.